Webcast ImageWebcast
Q3 2016 Stereotaxis Inc. Earnings Conference Call (Replay)
11/07/16 at 4:30 p.m. ET
Corporate Profile

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables.

The core components of Stereotaxis' systems have received regulatory clearance in the U.S., European Union, Canada, China, Japan, and elsewhere. The V-Sono™ ICE catheter manipulator, V-Loop™ variable loop catheter manipulator, and V-CAS™ catheter advancement system have received clearance in the U.S., Canada, and the European Union.

Financial News

Completed $24 million private placement equity financing Retired all outstanding debt at signific

ST. LOUIS, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in in

ST. LOUIS, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in in

STXS-Common
ExchangeOTCQX (US Dollar)
Price$0.55
Change (%) Stock is Up 0.02 (3.77%)
Volume90,930
Data as of 12/06/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Powered By EDGAR Online

Recent Filings
Filing DateForm
12/06/164
11/15/16EFFECT
11/15/16424B5
11/10/16S-1/A
Receive E-mail Alerts
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Enter your e-mail address here:
Investor Presentation
Download Documentation Q2 Investor Presentation
Investor Contacts
Martin Stammer
Chief Financial Officer
Stereotaxis, Inc.

© Copyright Stereotaxis 2015